National Heart, Lung, and Blood Institute logo
NHLBI Catalyze Program

NHLBI Catalyze — Reissue

Supports NHLBI translational pathways toward first-in-human feasibility testing.

Between cyclesNational Heart, Lung, and Blood InstituteUnited States
View on funder site
About

NHLBI Catalyze is a translational research program designed to help basic science discoveries in heart, lung, blood, and sleep (HLBS) biology cross the threshold into viable diagnostic and therapeutic candidates cleared for first-in-human testing. The program provides R61/R33 phased awards: the R61 phase functions as a milestone-gated feasibility period, and the R33 phase funds execution after mil…

What this grant funds

Translational research facilitating HLBS basic science discoveries into diagnostic and therapeutic candidates cleared for first-in-human testing, covering enabling platforms, small molecules, biologics, and devices.

Key facts
CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Annual
Next deadlineiThe next date applications are due. Rolling means you can apply any time.—
Decision timeiTypical time from the deadline to the funder's decision.—
Project durationiHow long the funded work is expected to run.—
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.—
Funding analytics

Sign up free to see the funding breakdown

Create free accountSign in
Industries

Sign up free to see the industries in scope

Create free accountSign in
Eligibility criteria

Sign up free to see the full eligibility

Create free accountSign in
Timeline

Sign up free to see the timeline

Create free accountSign in
Last verified: 24 Jul 2026Source: www.nhlbi.nih.gov